Skip to main content

Table 2 Mean NPI total scores at each time point for participants whose medication changed vs. those where medication remained the same

From: MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the intervention

 Baseline −2Baseline −1Baseline T08 week follow-up3 month follow-up6 month follow-up
Participants with a medication change
 Number of participantsn = 5n = 11n = 12n = 11n = 10n = 5
 Mean score (SD)34.8 (30.5)18.4 (19.7)17.4 (13.9)23.6 (22.6)18.3 (12.3)10.4 (8.4)
 Range10 to 700 to 710 to 510 to 770 to 330 to 18
Participants with no medication change
 Number of participantsn = 0n = 0n = 17n = 13n = 7n = 4
 Mean score (SD)N/AN/A22.3 (24.0)23.5 (28.7)45.1 (32.0)56.3 (39.7)
 RangeN/AN/A0 to 830 to 5922 to 1200 to 114
  1. Note: T0 is the baseline common to all participants, who received the medication review. Baseline −1 and − 2 refer to any previous baselining